APA

Möginger U., Resemann A., Martin C. E., Parameswarappa S., Govindan S., Wamhoff E., Broecker F., Suckau D., Pereira C. L., Anish C., Seeberger P. H. & Kolarich D. (20170103). Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. : Scientific reports.

Chicago

Möginger Uwe, Resemann Anja, Martin Christopher E, Parameswarappa Sharavathi, Govindan Subramanian, Wamhoff Eike-Christian, Broecker Felix, Suckau Detlev, Pereira Claney Lebev, Anish Chakkumkal, Seeberger Peter H and Kolarich Daniel. 20170103. Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. : Scientific reports.

Harvard

Möginger U., Resemann A., Martin C. E., Parameswarappa S., Govindan S., Wamhoff E., Broecker F., Suckau D., Pereira C. L., Anish C., Seeberger P. H. and Kolarich D. (20170103). Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. : Scientific reports.

MLA

Möginger Uwe, Resemann Anja, Martin Christopher E, Parameswarappa Sharavathi, Govindan Subramanian, Wamhoff Eike-Christian, Broecker Felix, Suckau Detlev, Pereira Claney Lebev, Anish Chakkumkal, Seeberger Peter H and Kolarich Daniel. Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. : Scientific reports. 20170103.